Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase

被引:41
|
作者
Maynard, Andrew [2 ]
Crosby, Renae M. [1 ]
Ellis, Byron [2 ]
Hamatake, Robert [1 ]
Hong, Zhi [1 ]
Johns, Brian A. [1 ]
Kahler, Kirsten M. [2 ]
Koble, Cecilia [1 ]
Leivers, Anna [1 ]
Leivers, Martin R. [1 ]
Mathis, Amanda [1 ]
Peat, Andrew J. [1 ]
Pouliot, Jeffrey J. [1 ]
Roberts, Christopher D. [1 ]
Samano, Vicente [1 ]
Schmidt, Rachel M. [2 ]
Smith, Gary K. [2 ]
Spaltenstein, Andrew [1 ]
Stewart, Eugene L. [2 ]
Thommes, Pia [3 ]
Turner, Elizabeth M. [1 ]
Voitenleitner, Christian [1 ]
Walker, Jill T. [1 ]
Waitt, Greg [2 ]
Weatherhead, Jason [1 ]
Weaver, Kurt [2 ]
Williams, Shawn [2 ]
Wright, Lois [2 ]
Xiong, Zhiping Z. [1 ]
Haigh, David [3 ]
Shotwell, J. Brad [1 ]
机构
[1] GlaxoSmithKline, Infect Dis Med Discovery Unit, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Platform Technol & Sci, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Infect Dis Ctr Excellence Drug Discovery, Stevenage SG1 1NY, Herts, England
关键词
HEPATITIS-C VIRUS; NONNUCLEOSIDE INHIBITORS; ANTIFUNGAL AGENT; RESISTANCE; MECHANISMS; NUCLEOTIDE; INITIATION; PROTEASE; SITE;
D O I
10.1021/jm400317w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A boronic acid moiety was found to be a critical pharmacophore for enhanced in vitro potency against wild-type hepatitis C replicons and known clinical polymorphic and resistant HCV mutant replicons. The synthesis, optimization, and structure-activity relationships associated with inhibition of HCV replication in a subgenomic replication system for a series of non-nucleoside boron-containing HCV RNA-dependent RNA polymerase (NS5B) inhibitors are described. A summary of the discovery of 3 (GSK5852), a molecule which entered clinical trials in subjects infected with HCV in 2011, is included.
引用
收藏
页码:1902 / 1913
页数:12
相关论文
共 50 条
  • [21] Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro
    Mo, HM
    Lu, LJ
    Pilot-Matias, T
    Pithawalla, R
    Mondal, R
    Masse, S
    Dekhtyar, T
    Ng, T
    Koev, G
    Stoll, V
    Stewart, KD
    Pratt, J
    Donner, P
    Rockway, T
    Maring, C
    Mollal, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) : 4305 - 4314
  • [22] Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase
    Shimizu, Hideaki
    Saito, Akatsuki
    Mikuni, Junko
    Nakayama, Emi E.
    Koyama, Hiroo
    Honma, Teruki
    Shirouzu, Mikako
    Sekine, Shun-ichi
    Shioda, Tatsuo
    PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (11):
  • [23] RNA Editing with Viral RNA-Dependent RNA Polymerase
    Ogasawara, Shinzi
    Yamada, Ai
    ACS SYNTHETIC BIOLOGY, 2022, 11 (01): : 46 - 52
  • [24] Insights into structural dynamics of allosteric binding sites in HCV RNA-dependent RNA polymerase
    Mittal, Lovika
    Kumari, Anita
    Suri, Charu
    Bhattacharya, Sankar
    Asthana, Shailendra
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (06): : 1612 - 1625
  • [25] Identification of a novel resistance mutation for benzimidazole inhibitors of the HCV RNA-dependent RNA polymerase
    Delang, Leen
    Froeyen, Mathy
    Herdewijn, Piet
    Neyts, Johan
    ANTIVIRAL RESEARCH, 2012, 93 (01) : 30 - 38
  • [26] An RNA-dependent RNA polymerase inhibitor for tick-borne encephalitis virus
    Gejji, Varun
    Svoboda, Pavel
    Stefanik, Michal
    Wang, Haoqi
    Salat, Jiri
    Eyer, Ludek
    Ruzek, Daniel
    Fernando, Sandun
    VIROLOGY, 2020, 546 : 13 - 19
  • [27] Nonnucleoside inhibitor of measles virus RNA-Dependent RNA polymerase complex activity
    White, Laura K.
    Yoon, Jeong-Joong
    Lee, Jin K.
    Sun, Aiming
    Du, Yuhong
    Fu, Haian
    Snyder, James P.
    Plemper, Richard K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) : 2293 - 2303
  • [28] RNA-DEPENDENT RNA POLYMERASE IN CHINESE CABBAGE
    ASTIERMA.S
    CORNUET, P
    BIOCHIMICA ET BIOPHYSICA ACTA, 1971, 232 (03) : 484 - &
  • [29] Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase
    Howe, AYM
    Bloom, J
    Baldick, CJ
    Benetatos, CA
    Cheng, HM
    Christensen, JS
    Chunduru, SK
    Coburn, GA
    Feld, B
    Gopalsamy, A
    Gorczyca, WP
    Herrmann, S
    Johann, S
    Jiang, XQ
    Kimberland, ML
    Krisnamurthy, G
    Olson, M
    Orlowski, M
    Swanberg, S
    Thompson, I
    Thorn, M
    Del Vecchio, A
    Young, DC
    van Zeijl, M
    Ellingboe, JW
    Upeslacis, J
    Collett, M
    Mansour, TS
    O'Connell, JF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4813 - 4821
  • [30] Origin and Evolution of RNA-Dependent RNA Polymerase
    de Farias, Savio T.
    Junior, Ariosvaldo P. dos Santos
    Rego, Thais G.
    Jose, Marco V.
    FRONTIERS IN GENETICS, 2017, 8